Copertina

Biological agent exerts therapeutic effects by reversing abnormalities in amino acid metabolic pathways in psoriasis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Haijun Miao, Yaxing Bai, Shengxian Shen, Mengyang Chu, Chang Miao, Jundan Yang, Xia Li, Liang Li, Shuai Shao, Gang Wang, Erle Dang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Experimental Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The Impacts of Seasonal Factors on Psoriasis
di: Jundan Yang, et al.
Pubblicazione: (2025)

Biologic Efficacy by BMI in Moderate‐To‐Severe Psoriasis: A Real‐World Cohort Study
di: Xin Shen, et al.
Pubblicazione: (2026)

Cross Disease Single‐Cell Meta‐Analysis Deciphers Conserved Pan‐Inflammatory Circuits and Divergent Endothelial Rewiring in Inflammatory Skin Pathogenesis
di: Jiaxin Xu, et al.
Pubblicazione: (2025)

The impacts of biologic treatment on metabolic profiling in psoriasis
di: Sichun Deng, et al.
Pubblicazione: (2024)

Histone modification in psoriasis: Molecular mechanisms and potential therapeutic targets
di: Ruifeng Liu, et al.
Pubblicazione: (2024)

Biologic treatment sequences in moderate‐to‐severe psoriasis
di: Samantha Ting, et al.
Pubblicazione: (2024)

Biologic therapy increases Demodex density in psoriasis patients
di: Hasan Aksoy, et al.
Pubblicazione: (2024)

Improvement of psoriasis vulgaris in a patient with obesity after bariatric and metabolic surgery: A case letter
di: Shinji Mitsuyama, et al.
Pubblicazione: (2024)

Biologic therapies and psoriatic arthritis risk in psoriasis: A systematic review and meta‐analysis
di: Li Yang, et al.
Pubblicazione: (2026)

Biologic treatment outcomes in generalized pustular psoriasis of pregnancy: A systematic review
di: YuFei Wang, et al.
Pubblicazione: (2024)

The effects of fatty acids on psoriasis: A two‐sample mendelian randomization study
di: Yuanjie Huang, et al.
Pubblicazione: (2024)

Transcriptomic meta‐analysis identifies core molecular pathways in plaque psoriasis
di: Teresa Torres‐Moral, et al.
Pubblicazione: (2026)

Rapid response of nail psoriasis to secukinumab in patients with moderate to severe psoriasis after 12 weeks of treatment with a total of 24 weeks of follow‐up
di: Gang Min Go, et al.
Pubblicazione: (2024)

Risk of multiple sclerosis in patients with psoriasis receiving anti‐IL ‐17 agents: A case‐based review
di: Sotirios G. Tsiogkas, et al.
Pubblicazione: (2024)

The amino acid transporter SLC16A10 promotes melanogenesis by facilitating the transportation of phenylalanine
di: Liping Luo, et al.
Pubblicazione: (2024)

Sodium intake: An emerging dietary target in psoriasis
di: Stephen Chu‐Sung Hu, et al.
Pubblicazione: (2025)

eIF4E plays the role of a pathogenic gene in psoriasis, and the inhibition of eIF4E phosphorylation ameliorates psoriasis‐like skin damage
di: Ruijie Wang, et al.
Pubblicazione: (2024)

¿Qué es la psoriasis?
Pubblicazione: (2025)

IGFBP‐rP1 is a potential therapeutic target in androgenic alopecia
di: Lijuan Zhou, et al.
Pubblicazione: (2024)

Fast freezing inhibits melanin synthesis of melanocytes by modulating the Wnt/β‐catenin signalling pathway
di: Siyun Wu, et al.
Pubblicazione: (2024)

Umbilical psoriasis is not relevant to psoriatic arthritis
di: Maki Takada, et al.
Pubblicazione: (2024)

Apremilast treatment for pediatric inverse psoriasis
di: Jun Wang, et al.
Pubblicazione: (2024)

Erythrokeratodermia Variabilis et Progressiva 4 With KDSR Mutations: A Case Report
di: Weiqi Ren, et al.
Pubblicazione: (2026)

Defactinib inhibits FAK phosphorylation and regulates psoriasis via attenuating hyperproliferation of keratinocytes
di: Yuyue Zuo, et al.
Pubblicazione: (2024)

Biologics for treatment of paediatric plaque psoriasis: A systematic review and network meta‐analysis
di: Abdullah Ali Aljalfan, et al.
Pubblicazione: (2025)

Efficacy and safety of epidural block with lidocaine for refractory severe plaque psoriasis: An open‐label pilot study in real world setting
di: Xin Xu, et al.
Pubblicazione: (2024)

The effect of abnormal secretion of DKK1 by fibroblasts on melanocytes function in vitiligo
di: Jiayi Chen, et al.
Pubblicazione: (2024)

Sclerosing cholangitis exacerbated by widespread pustular psoriasis
di: Akane Ogaya, et al.
Pubblicazione: (2024)

Systemic therapy for psoriasis and the risk of cutaneous infections
di: Yuko Higashi, et al.
Pubblicazione: (2024)

Image‐based remote evaluation of PASI scores with psoriasis by the YOLO‐v4 algorithm
di: Heng Yin, et al.
Pubblicazione: (2024)

Risk of adverse events of psoriasis treatment with biologic agents and new small molecules—BIOBADADERM Registry
di: María Olivares‐Guerrero, et al.
Pubblicazione: (2025)

Effects on peripheral and central nervous system of key inflammatory intercellular signalling peptides and proteins in psoriasis
di: Jue Tang, et al.
Pubblicazione: (2024)

Epidemiological analysis of the patients with psoriasis in Asian countries and region using the same clinical case cards between 2020 and 2022
di: Michio Tokuyama, et al.
Pubblicazione: (2024)

Regional differences in the prevalence of generalized pustular psoriasis in Japan
di: Hideki Fujita, et al.
Pubblicazione: (2024)

Effective management of coexisting bullous pemphigoid and psoriasis with bimekizumab
di: Ken Okamura, et al.
Pubblicazione: (2024)

Predictive factors for responders to deucravacitinib treatment in patients with psoriasis
di: Teppei Hagino, et al.
Pubblicazione: (2024)

Can imiquimod really provoke psoriasis?
di: Katinka Ónodi, et al.
Pubblicazione: (2024)

Targeting the NLRP3 inflammasome in psoriasis
di: Xiuhui Chen, et al.
Pubblicazione: (2024)

Ocular complications in patients with psoriasis: Is dry eye associated with psoriasis?
di: Marina Talamonti, et al.
Pubblicazione: (2024)

Risk factors and early detection of joint damage in patients with psoriasis: a case–control study
di: Amin Yao, et al.
Pubblicazione: (2024)